Thrombectomy Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Thrombectomy Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The thrombectomy devices market is expected to register a CAGR of 5% over the forecast period (2022-2027).

The COVID-19 outbreak severely impacted the thrombectomy market device market growth. The strict lockdowns and government restrictions have stopped the spread of the virus but slowed down the supply of these devices. Also, the government has applied the guidelines to delay non-essential surgeries, as a result, many surgical procedures were delayed globally and people had suffered a lot due to this. Also, these government restrictions slowed down the neurological procedures and the number of neuro thrombectomy procedures globally. For instance, in 2021 according to the data published by the International Journal of Stroke reported that the number of mechanical thrombectomy procedures got decreased by 12.7% during the initial three months of the pandemic. The onset of the COVID-19 pandemic has led to a rise in patients suffering from chronic diseases. The effects of coronavirus on the health of patients have increased cases of respiratory failures resulting in deaths. At the beginning of the pandemic, a significant decline in the use of mechanical thrombectomy was observed worldwide. Besides, postponement in treatments using mechanical thrombectomy due to infection control measures has as well negatively impacted the market prospects. Although COVID-19 has disrupted several healthcare activities, the thrombectomy devices market continued to witness robust growth. The higher risk of thromboembolism among COVID-19 patients led to increased demand for thrombectomy procedures thereby boosting market revenue.

The main driving features for this market are the growing geriatric population leading to an increase in cardiovascular diseases (CVDs) related to patients, technological advancements in medical devices used for capturing blood clots, and increased awareness regarding the early diagnosis of diseases. The growing geriatric population is leading in driving this market. The world is expected to witness a demographic shift over a few decades and the geriatric population is expected to dominate. Since, the geriatric population and increasing chronic diseases are rising globally and ultimately propelling the demand for thrombectomy devices, thereby contributing to the market growth.

The increasing incidence of ischaemic stroke has introduced the need to launch advanced products on market. The advancement and launch of new devices like suction devices, clot retrievers, and aspiration catheters based on advanced technology for ischaemic stroke are driving the market. For instance, in 2021 Phenox GmbH launched pRESET 6-50 mechanically thrombectomy devices globally to increase its technology for acute ischemic stroke. This product has the longest stent retriever in the phenoxy product portfolio.

The abovementioned aforesaid reasons the market is expected to show significant growth over the forecast period, however shortage of trained professionals, and high cost and difficultly use of devices for complex morphologies, maybe the restrain for this market.

Key Market TrendsThe Mechanical Thrombectomy Devices Segment is the largest segment of the thrombectomy devices market to witness the highest growth over the forecast period.

Mechanical thrombectomy refers to a new technique of stroke treatment that eliminates blood clots from the brain's major blood arteries. The operation is advised for individuals who have had an acute ischemic stroke caused by a major arterial obstruction in the brain's anterior circulation. Growing preference for the method is likely to augur well for the global mechanical thrombectomy market shortly.

However, with a rise in the burden of ischemic strokes across the globe, a novel treatment option known as mechanical thrombectomy has been made available by medical device companies. For instance, in 2021 NeuroVasv announced the ENVI-SR Mechanical Thrombectomy System (ENVI-SR), a stent-retriever being developed by NeuroVasc Technologies for the removal of blood clots in patients with acute ischemic stroke due to large vessel occlusion. For another instance, in July 2021, Surmodics, a leading provider of medical devices and in vitro diagnostic technologies to the health care industry, announced the acquisition of privately held Vetex Medical Limited. The Galway, Ireland-based medical device developer and manufacturer has focused exclusively on venous clot removal solutions. The transaction expands Surmodics’ thrombectomy portfolio with a second United States Food and Drug Administration (USFDA) 510(k)-cleared device, the ReVene Thrombectomy Catheter. The ReVene mechanical thrombectomy catheter is specifically designed to remove large, mixed-morphology blood clots commonly found with venous thromboembolism (VTE). The device’s dual action technology efficiently removes mixed-morphology clots in a single session, minimizing the need for thrombolytics and without capital equipment. Due to these technological advancements, the mechanical thrombectomy device segment is expected to be the largest segment, and witness to show significant growth over the forecast period.

Mechanical thrombectomy significantly reduces stroke-related disabilities in patients when used in conjunction with tPA and other medical treatments. The rise in demand for minimally invasive surgical procedures and favorable reimbursement policies for cardiovascular and neurovascular procedures are expected to boost demand for mechanical thrombectomy devices during the forecast period.

North America Expected to Dominate the Market Over the Forecast Period

The increasing burden of cardiac patients, technological advancements in the devices to attain better clinical outcomes, and increasing demand for minimally invasive products are driving the thrombectomy, presence of key market players driving the thrombectomy devices market in North America.

The rising cases of cardiac patients, suffering from heart attack and cardiac arrest are increasing in the North American region, which is mainly attributed due their lifestyles and diet pattern another reason for the increasing burden of cardiac patients in that region. For instance, in 2022 Centre for Disease Control and Prevention (CDC) reported that 805,000 people had a heart attack in the United States. Of these 605,000 are a first heart attack and 200,000 happen to people who have already had a heart attack. For another instance, in 2022 an article published in the National Library of Medicine reported that in the United States, about 610,000 people die of heart disease every year. That is 1 of every 4 deaths. Coronary heart disease is the leading cause of death in the Western world killing over 370,000 people annually. On average, about 735,000 Americans have a heart attack every year. Thus the high burden of cardiac diseases in the region drives the thrombectomy devices market.

Key market players are also involved in marketing strategies like a merger, acquisitions, etc in the segment tracked to gain a competitive edge in the region. For instance, in September 2021, Abbott announced the acquisition of Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots. For another instnace, in August 2021, Stryker Neurovascular received the regulatory United States Food and Drug Administration (USFDA) approval for their Trevo NXT Pro Vue Retriever, a class II medical device classified as a neurovascular mechanical thrombectomy device for acute ischemic stroke. Such acquistitions and advancement is driving the market in North America.

Therefore, due to the favorable reimbursement scenario for medical devices and aforementioned factors, the market is estimated to grow consistently in the North American region.

Competitive Landscape

The thrombectomy market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares including Argon Medical Devices Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic PLC, Penumbra Inc., Koninklijke Philips NV (Spectranetics), Terumo Corporation, Straub Medical AG, and Stryker Corporation.

The competitive landscape covers a Business Overview, Financials, Products and Strategies, and Recent Developments.

Additional Benefits:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.


1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Geriatric Population Leading to Increase in CVDs Related Patients
4.2.2 Technological Advancements in Medical Devices Used for Capturing Blood Clots
4.2.3 Increased Awareness Regarding Early Diagnosis of Diseases
4.3 Market Restraints
4.3.1 Shortage of Trained Professionals
4.3.2 High Cost and Difficultly Use of Devices for Complex Morphologies
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Aspiration Thrombectomy Devices
5.1.2 Mechanical Thrombectomy Devices
5.1.3 Ultrasonic Thrombectomy Devices
5.1.4 Other Product Types
5.2 By Application
5.2.1 Cardiovascular Thrombectomy
5.2.2 Neurovascular Thrombectomy
5.2.3 Peripheral Vascular Thrombectomy
5.3 By End User
5.3.1 Hospitals/Clinics
5.3.2 Ambulatory Centers
5.3.3 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Argon Medical Devices Inc.
6.1.2 Boston Scientific Corporation
6.1.3 Edwards Lifesciences Corporation
6.1.4 Johnson & Johnson
6.1.5 Medtronic PLC
6.1.6 Penumbra Inc.
6.1.7 Koninklijke Philips NV (Spectranetics)
6.1.8 Terumo Corporation
6.1.9 Straub Medical AG
6.1.10 Stryker Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings